Rapimig (zolmitriptan) tablets 5 mg. #2

$0.00

Manufactured in: Malta

Rapimig tablets provide fast relief for migraine attacks in adults by targeting serotonin receptors to constrict blood vessels and reduce inflammation.

Out of stock

SKU: MED7411 Category:

Description

Rapimig (zolmitriptan) Dispersible Tablets 5 mg.

Rapimig is a medication that comes in the form of dispersible tablets containing 5 mg. of zolmitriptan. Zolmitriptan is a selective serotonin receptor agonist used to treat migraines and cluster headaches. These tablets are designed to dissolve quickly in the mouth, making it easier for patients who have difficulty swallowing traditional tablets.

Indications

Rapimig is indicated for the acute treatment of migraine attacks with or without aura in adults. It is not intended for the prevention of migraines or the treatment of other types of headaches.

Mechanism of Action

Zolmitriptan works by binding to serotonin receptors in the brain, causing blood vessels to constrict and reducing inflammation associated with migraines. This action helps to alleviate the pain and other symptoms of a migraine attack.

Dosage and Administration

The usual dose of Rapimig is one 5 mg. tablet taken as soon as possible after the onset of a migraine attack. The tablet should be placed on the tongue and allowed to dissolve without chewing. If the migraine symptoms do not improve after taking the first tablet, a second tablet may be taken at least 2 hours after the first dose.

Contraindications

Rapimig is contraindicated in patients with a history of heart disease, uncontrolled high blood pressure, or hypersensitivity to zolmitriptan or any other components of the tablet. It should not be used in patients with a history of stroke, peripheral vascular disease, or ischemic bowel disease.

Adverse Reactions

Common side effects of Rapimig may include dizziness, drowsiness, nausea, and dry mouth. Rare but serious side effects may include chest pain, shortness of breath, or changes in vision. Patients should seek medical attention if they experience any severe or persistent side effects.

Drug Interactions

Patients should inform their healthcare provider about all medications they are currently taking, including prescription, over-the-counter, and herbal supplements. Zolmitriptan may interact with other medications, such as selective serotonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAOIs), and ergotamine derivatives.

Storage

Rapimig should be stored at room temperature away from moisture and heat. Keep the tablets in their original packaging and out of reach of children and pets.

Warnings and Precautions

Before taking Rapimig, patients should inform their healthcare provider about any medical conditions they have, especially heart disease, high blood pressure, liver or kidney disease, or a history of stroke. Patients should also avoid driving or operating heavy machinery until they know how this medication affects them.

Overdose

In case of an overdose, patients should seek immediate medical attention. Symptoms of overdose may include severe dizziness, fainting, or seizures.

Pregnancy and Lactation

It is important to consult a healthcare provider before taking Rapimig during pregnancy or while breastfeeding. The potential risks and benefits should be carefully considered before using this medication.

Conclusion

Rapimig (zolmitriptan) dispersible tablets are a convenient and effective treatment option for migraine attacks. By quickly dissolving in the mouth, these tablets provide fast relief for patients experiencing the pain and other symptoms associated with migraines. Patients should follow the dosage instructions provided by their healthcare provider and seek medical attention if they experience any severe or persistent side effects.